Drug Safety, Medical Device, And Laboratory Regulation
US Congress 116th Congress
IMPROVE Addiction Care Act Improving Medicaid Programs' Response to Overdose Victims and Enhancing Addiction Care Act [HB-8388]
Establishes additional requirements for state Medicaid drug-use review programs with respect to individuals who experience opioid-related overdoses. Specifically, programs must include protocols that (1) connect individuals who have experienced an opioid-related overdose within the last five years to appropriate treatment; (2) notify providers who prescribe opioids about subsequent fatal overdoses; (3) ensure providers are notified about an individual's history of opioid-use disorder, overdoses, or poisonings; and (4) educate providers about proper
(continued...)
HB-8388: IMPROVE Addiction Care Act Improving Medicaid Programs' Response to Overdose Victims and Enhancing Addiction Care Act
Sponsored by: Sen. Markwayne Mullin
Introduced In House on 09/24/2020
IMPROVE Addiction Care Act Improving Medicaid Programs' Response to Overdose Victims and Enhancing Addiction Care Act [S.4702]
Establishes additional requirements for state Medicaid drug-use review programs with respect to individuals who experience opioid-related overdoses. Specifically, programs must include protocols that (1) connect individuals who have experienced an opioid-related overdose within the last five years to appropriate treatment; (2) notify providers who prescribe opioids about subsequent fatal overdoses; (3) ensure providers are notified about an individual's history of opioid-use disorder, overdoses, or poisonings; and (4) educate providers about proper
(continued...)
S.4702: IMPROVE Addiction Care Act Improving Medicaid Programs' Response to Overdose Victims and Enhancing Addiction Care Act
Sponsored by: Sen. Joe Manchin
Read Twice And Referred To The Committee On Finance. on 09/24/2020
Continuing Appropriations Act, 2021 and Other Extensions Act [HB-8337]
Provides continuing FY2021 appropriations to federal agencies and extends expiring programs that address health care, surface transportation, agriculture, veterans benefits, and other issues. DIVISION A--CONTINUING APPROPRIATIONS ACT, 2021 Continuing Appropriations Act, 2021 This division provides continuing FY2021 appropriations to federal agencies through December 11, 2020. It is known as a continuing resolution (CR) and prevents a government shutdown that would otherwise occur if the FY2021 appropriations bills have not been enacted when FY2021
(continued...)
HB-8337: Continuing Appropriations Act, 2021 and Other Extensions Act
Sponsored by: Rep. Nita Lowey
Became Public Law No: 116-159. (txt | Pdf) on 10/01/2020
Independent Advisory Committee Review of E-Cigarette Applications Act [HB-8343]
Requires the Food and Drug Administration (FDA) to refer to the Tobacco Products Scientific Advisory Committee certain applications for premarket review of a new tobacco product, such as an e-cigarette. (Currently, the FDA may refer an application to the committee but is generally not required to do so.) The FDA shall notify the committee when receiving such an application. If the FDA intends to issue an order on an application, the FDA shall refer the application to the committee. With respect to a referred application, the committee shall make
(continued...)
HB-8343: Independent Advisory Committee Review of E-Cigarette Applications Act
Sponsored by: Rep. Eleanor Norton
Introduced In House on 09/22/2020
EHDC Act of 2020 Ending Health Disparities During COVID–19 Act of 2020 [HB-8200]
Expands COVID-19 (i.e., coronavirus disease 2019) relief efforts, expands data collection and health literacy, supports research, promotes diversity in the health professional workforce, increases access to telehealth and other health care, and otherwise addresses the health of minority populations and immigrants. For example, the bill provides funding for emergency aid and services, grants to address COVID-19 health inequities, grants to address social determinants of health, and payments for language services. It also expands COVID-19 testing
(continued...)
HB-8200: EHDC Act of 2020 Ending Health Disparities During COVID–19 Act of 2020
Sponsored by: Rep. Raul Grijalva
Referred To The Subcommittee On Economic Development, Public Buildings, And Emergency Management. on 09/14/2020
Horseracing Integrity and Safety Act of 2020 [S.4547]
Recognizes the Horseracing Integrity and Safety Authority for purposes of developing and implementing a horseracing anti-doping and medication control program and a racetrack safety program. The authority shall establish an anti-doping and medication control standing committee and a racetrack safety standing committee to provide guidance to the authority on the development and maintenance of the programs. The Federal Trade Commission (FTC) shall have oversight over the authority. The authority shall submit to the FTC any proposed rule, standard,
(continued...)
S.4547: Horseracing Integrity and Safety Act of 2020
Sponsored by: Sen. Dianne Feinstein
Read Twice And Referred To The Committee On Commerce, Science, And Transportation. on 09/09/2020
Taxpayer Research and Coronavirus Knowledge Act of 2020 [S.4539]
A bill to direct the Secretary of Health and Human Services and other Federal officials to compile into a searchable database information relating to Federal support for biomedical research and development related to COVID-19, and for other purposes.
S.4539: Taxpayer Research and Coronavirus Knowledge Act of 2020
Sponsored by: Sen. Jeff Merkley
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 09/08/2020
Ally’s Act [S.4532]
A bill to amend title XXVII of the Public Health Service Act and the Patient Protection and Affordable Care Act to require coverage of hearing devices and systems in certain private health insurance plans, and for other purposes.
S.4532: Ally’s Act
Sponsored by: Sen. Elizabeth Warren
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 09/08/2020
Biosimilar Insulin Access Act of 2020 [HB-8190]
To amend the Public Health Service Act to deem any insulin that is determined by the Secretary to be biosimilar to the reference product to be interchangeable with the reference product, and for other purposes.
HB-8190: Biosimilar Insulin Access Act of 2020
Sponsored by: Rep. Glenn Grothman
Sponsor Introductory Remarks On Measure. (cr H4487) on 09/16/2020
Maternal Health Pandemic Response Act of 2020 [HB-8027]
Addresses maternal health during the COVID-19 (i.e., coronavirus disease 2019) emergency by supporting data collection, development of COVID-19 therapeutics and workplace protections, and other activities. Specifically, the Department of Health and Human Services must issue guidance for states and local health departments on collecting data on pregnancy and postpartum status in conjunction with COVID-19 tests. In addition, the bill provides funds for the Centers for Disease Control and Prevention (CDC) to expand particular maternal health surveillance
(continued...)
HB-8027: Maternal Health Pandemic Response Act of 2020
Sponsored by: Rep. Eleanor Norton
Referred To The Subcommittee For Indigenous Peoples Of The United States. on 09/04/2020
MMEDS Act of 2020 Medical Manufacturing, Economic Development, and Sustainability Act of 2020 [S.4467]
Provides incentives for relocating medical manufacturing facilities in the United States and for manufacturing medical products (i.e., drugs and devices) in economically distressed zones. Specifically, the bill allows a income tax credit for 40% of the sum of wages paid in a medical product manufacturing economically distressed zone, employee fringe benefit expenses, and depreciation and amortization allowances with respect to qualified medical product manufacturing facility property, and a credit for economically distressed zone products and services
(continued...)
S.4467: MMEDS Act of 2020 Medical Manufacturing, Economic Development, and Sustainability Act of 2020
Sponsored by: Sen. Marco Rubio
Read Twice And Referred To The Committee On Finance. on 08/06/2020
Environmental Justice For All Act [S.4401]
Establishes several environmental justice requirements, advisory bodies, and programs to address the disproportionate adverse human health or environmental effects of federal laws or programs on communities of color, low-income communities, or tribal and indigenous communities. Specifically, the bill prohibits disparate impacts on the basis of race, color, or national origin as discrimination. Aggrieved persons may seek legal remedy when faced with such discrimination. In addition, the bill directs agencies to follow certain requirements concerning
(continued...)
S.4401: Environmental Justice For All Act
Sponsored by: Sen. Dianne Feinstein
Read Twice And Referred To The Committee On Environment And Public Works. on 08/03/2020
Substance Regulation and Safety Act of 2020 [S.4386]
A bill to decriminalize and reschedule cannabis, to provide for the regulation of cannabis and cannabis products to protect public health and safety, and for other purposes.
S.4386: Substance Regulation and Safety Act of 2020
Sponsored by: Sen. Tina Smith
Read Twice And Referred To The Committee On The Judiciary. on 07/30/2020
Intelligence Authorization Act for Fiscal Year 2021 [HB-7856]
Authorizes various intelligence-related activities for FY2021 and contains other related provisions. The bill's provisions include those requiring each intelligence community element to notify Congress before conducting certain activities, including providing support to a government response to a domestic civil disturbance, with some exceptions, or engaging in an activity pursuant to a presidential emergency action document; generally prohibiting the intelligence community from awarding a contract for a national security satellite that uses a star
(continued...)
HB-7856: Intelligence Authorization Act for Fiscal Year 2021
Sponsored by: Sen. Adam Schiff
Reported By The Committee On Intelligence. H. Rept. 116-565. on 10/30/2020